Gyre Therapeutics (GYRE) announced the appointment of Dan Weng, M.D., to its Board of Directors. Weng has served as President and CEO of Medelis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GYRE: